7th Dermatology Drug Development Summit in Boston: Scarletred Joins as Lead & Hosting Partner and Expert Speaker
The 7th Dermatology Drug Development Summit in Boston, USA, for inflammatory skin diseases presents novel therapeutics for rare and common skin diseases such as Atopic Dermatitis, Hidradenitis suppurativa, and more.
The annual Summit will provide insight into current dermatology drug developments by experts from academic institutions, drug developers, and service providers. This year, the focus lies on JAK inhibitors approved for the treatment of rare dermatological disorders.
SCARLETRED joins the Summit as a lead and hostsing partner with our CEO, Harald Schnidar, Ph.D., MBA, presenting as an expert speaker about our imaging and analysis technology Scarletred®Vision in Rosacea, Hidradenitis Suppurativa, and other diseases.
Register online and check out the complete event Guide on the homepage of the 7th Dermatology Drug Development Summit.
Like the article? Spread the word
7th Dermatology Drug Development Summit
As a lead & hosting partner of the Drug Development Summit in Boston, USA, our CEO Harald Schnidar will present his talk as an expert speaker about AI assisted objective skin imaging and analysis of skin diseases and drug effects in clinical trials.